Pulse nav.journalClub Tendencias Explorar Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer | Synapse

April 10, 2024

Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Platinum-based chemotherapy is the recommended adjuvant treatment for patients with resectable,

Me gusta

Guardar

Compartir

Me gusta

Guardar

Compartir

Cite This Study

Wu et al. (Wed,) studied this question.

synapsesocial.com/papers/68e6f976b6db643587674118 https://doi.org/https://doi.org/10.1056/nejmoa2310532